246 related articles for article (PubMed ID: 32291170)
1. Efficacy of antibacterial envelope in prevention of cardiovascular implantable electronic device infections in high-risk patients: A systematic review and meta-analysis.
Ullah W; Nadeem N; Haq S; Thelmo FL; Abdullah HM; Haas DC
Int J Cardiol; 2020 Sep; 315():51-56. PubMed ID: 32291170
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of the antibacterial envelope to prevent cardiac implantable electronic device infection in a high-risk population.
Chaudhry U; Borgquist R; Smith JG; Mörtsell D
Europace; 2022 Dec; 24(12):1973-1980. PubMed ID: 35989511
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.
Tarakji KG; Mittal S; Kennergren C; Corey R; Poole JE; Schloss E; Gallastegui J; Pickett RA; Evonich R; Philippon F; McComb JM; Roark SF; Sorrentino D; Sholevar D; Cronin E; Berman B; Riggio D; Biffi M; Khan H; Silver MT; Collier J; Eldadah Z; Wright DJ; Lande JD; Lexcen DR; Cheng A; Wilkoff BL;
N Engl J Med; 2019 May; 380(20):1895-1905. PubMed ID: 30883056
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a Bio-Absorbable Antibacterial Envelope to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Subjects.
Kolek MJ; Patel NJ; Clair WK; Whalen SP; Rottman JN; Kanagasundram A; Shen ST; Saavedra PJ; Estrada JC; Abraham RL; Ellis CR
J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1111-6. PubMed ID: 26222980
[TBL] [Abstract][Full Text] [Related]
5. Risk Stratifying and Prognostic Analysis of Subclinical Cardiac Implantable Electronic Devices Infection: Insight From Traditional Bacterial Culture.
Lin G; Zou T; Dong M; Liu J; Cui W; Tong J; Shi H; Chen H; Chong J; Lyu Y; Wu S; Wang Z; Jin X; Gao X; Sun L; Qu Y; Yang J
J Am Heart Assoc; 2021 Nov; 10(22):e022260. PubMed ID: 34729993
[TBL] [Abstract][Full Text] [Related]
6. Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients.
Kolek MJ; Dresen WF; Wells QS; Ellis CR
Pacing Clin Electrophysiol; 2013 Mar; 36(3):354-61. PubMed ID: 23252988
[TBL] [Abstract][Full Text] [Related]
7. Clinical Presentation, Timing, and Microbiology of CIED Infections: An Analysis of the WRAP-IT Trial.
Sohail MR; Corey GR; Wilkoff BL; Poole JE; Mittal S; Kennergren C; Greenspon AJ; Cheng A; Lande JD; Lexcen DR; Tarakji KG
JACC Clin Electrophysiol; 2021 Jan; 7(1):50-61. PubMed ID: 33478712
[TBL] [Abstract][Full Text] [Related]
8. Retrospective comparative analysis of cardiovascular implantable electronic device infections with and without the use of antibacterial envelopes.
Hassoun A; Thottacherry ED; Raja M; Scully M; Azarbal A
J Hosp Infect; 2017 Mar; 95(3):286-291. PubMed ID: 28131641
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.
Henrikson CA; Sohail MR; Acosta H; Johnson EE; Rosenthal L; Pachulski R; Dan D; Paladino W; Khairallah FS; Gleed K; Hanna I; Cheng A; Lexcen DR; Simons GR
JACC Clin Electrophysiol; 2017 Oct; 3(10):1158-1167. PubMed ID: 29759500
[TBL] [Abstract][Full Text] [Related]
10. Randomized Trial of Stand-Alone Use of the Antimicrobial Envelope in High-Risk Cardiac Device Patients.
Ellis CR; Greenspon AJ; Andriulli JA; Gould PA; Carillo RG; Kolek MJ; Donegan R; Amaral AP; Mittal S
Circ Arrhythm Electrophysiol; 2023 May; 16(5):e011740. PubMed ID: 36960716
[TBL] [Abstract][Full Text] [Related]
11. Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score.
Ahmed FZ; Blomström-Lundqvist C; Bloom H; Cooper C; Ellis C; Goette A; Greenspon AJ; Love CJ; Johansen JB; Philippon F; Tarakji KG; Holbrook R; Sherfesee L; Xia Y; Seshadri S; Lexcen DR; Krahn AD
Europace; 2021 Sep; 23(9):1446-1455. PubMed ID: 33755136
[TBL] [Abstract][Full Text] [Related]
12. Proposal for a Novel Score to Determine the Risk of Cardiac Implantable Electronic Device Infection.
Calderón-Parra J; Sánchez-Chica E; Asensio-Vegas Á; Fernández-Lozano I; Toquero-Ramos J; Castro-Urda V; Royuela-Vicente A; Ramos-Martínez A
Rev Esp Cardiol (Engl Ed); 2019 Oct; 72(10):806-812. PubMed ID: 30340923
[TBL] [Abstract][Full Text] [Related]
13. The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: Long-term follow-up.
Mittal S; Wilkoff BL; Kennergren C; Poole JE; Corey R; Bracke FA; Curnis A; Addo K; Martinez-Arraras J; Issa ZF; Redpath C; Moubarak J; Khelae SK; Boersma LVA; Korantzopoulos P; Krueger J; Lande JD; Morss GM; Seshadri S; Tarakji KG
Heart Rhythm; 2020 Jul; 17(7):1115-1122. PubMed ID: 32087357
[TBL] [Abstract][Full Text] [Related]
14. Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation.
Shariff N; Eby E; Adelstein E; Jain S; Shalaby A; Saba S; Wang NC; Schwartzman D
J Cardiovasc Electrophysiol; 2015 Jul; 26(7):783-9. PubMed ID: 25845917
[TBL] [Abstract][Full Text] [Related]
15. Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB).
Sohail MR; Palraj BR; Khalid S; Uslan DZ; Al-Saffar F; Friedman PA; Hayes DL; Lohse CM; Wilson WR; Steckelberg JM; Baddour LM
Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):137-44. PubMed ID: 25504648
[TBL] [Abstract][Full Text] [Related]
16. Use of antibiotic envelopes to prevent cardiac implantable electronic device infections: A meta-analysis.
Koerber SM; Turagam MK; Winterfield J; Gautam S; Gold MR
J Cardiovasc Electrophysiol; 2018 Apr; 29(4):609-615. PubMed ID: 29364546
[TBL] [Abstract][Full Text] [Related]
17. Impact of Cardiac Implantable Electronic Device Infection: A Clinical and Economic Analysis of the WRAP-IT Trial.
Wilkoff BL; Boriani G; Mittal S; Poole JE; Kennergren C; Corey GR; Love JC; Augostini R; Faerestrand S; Wiggins SS; Healey JS; Holbrook R; Lande JD; Lexcen DR; Willey S; Tarakji KG;
Circ Arrhythm Electrophysiol; 2020 May; 13(5):e008280. PubMed ID: 32281393
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study.
Malagù M; Vitali F; Brieda A; Cimaglia P; De Raffele M; Tazzari E; Musolino C; Balla C; Serenelli M; Cultrera R; Rapezzi C; Bertini M
Europace; 2022 Mar; 24(3):413-420. PubMed ID: 34487163
[TBL] [Abstract][Full Text] [Related]
19. Impact of timing of transvenous lead removal on outcomes in infected cardiac implantable electronic devices.
Lee JZ; Majmundar M; Kumar A; Thakkar S; Patel HP; Sorajja D; Valverde AM; Kalra A; Cha YM; Mulpuru SK; Asirvatham SJ; Desimone CV; Deshmukh AJ
Heart Rhythm; 2022 May; 19(5):768-775. PubMed ID: 34968739
[TBL] [Abstract][Full Text] [Related]
20. CIED infection with either pocket or systemic infection presentation--complete device removal and long-term antibiotic treatment; long-term outcome.
Ihlemann N; Møller-Hansen M; Salado-Rasmussen K; Videbæk R; Moser C; Iversen K; Bundgaard H
Scand Cardiovasc J; 2016; 50(1):52-7. PubMed ID: 26485501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
